Edward James

414 total citations
14 papers, 298 citations indexed

About

Edward James is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Edward James has authored 14 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Edward James's work include Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Edward James is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Edward James collaborates with scholars based in United States and Pakistan. Edward James's co-authors include Muhammad Wasif Saif, Jill Lacy, Stacey Stein, Jeremy Kortmansky, Xiangyu Cong, Bryan Chang, Ronald R. Salem, Maeve Waldron-Lynch, Howard S. Höchster and Charles Cha and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Anti-Cancer Drugs.

In The Last Decade

Edward James

14 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward James United States 7 240 109 87 83 48 14 298
Jingbo Yi United States 7 170 0.7× 76 0.7× 25 0.3× 81 1.0× 38 0.8× 15 283
A. Fittipaldo United Kingdom 10 221 0.9× 58 0.5× 135 1.6× 105 1.3× 35 0.7× 15 415
Ana B. Galván Spain 9 112 0.5× 75 0.7× 27 0.3× 138 1.7× 34 0.7× 13 307
Tyler Izatt United States 8 94 0.4× 64 0.6× 38 0.4× 42 0.5× 45 0.9× 15 213
Susan Valmadre Australia 7 108 0.5× 70 0.6× 85 1.0× 38 0.5× 69 1.4× 11 319
N. Vardakis Greece 11 348 1.4× 113 1.0× 37 0.4× 201 2.4× 64 1.3× 35 436
Sun Chung United States 8 300 1.3× 78 0.7× 89 1.0× 112 1.3× 188 3.9× 11 390
Francesca Vecchione Italy 9 163 0.7× 69 0.6× 151 1.7× 47 0.6× 135 2.8× 15 520
Ulrika A. Hänninen Finland 7 159 0.7× 73 0.7× 19 0.2× 63 0.8× 48 1.0× 10 330
Akiko Ogiya Japan 12 199 0.8× 288 2.6× 24 0.3× 56 0.7× 122 2.5× 43 424

Countries citing papers authored by Edward James

Since Specialization
Citations

This map shows the geographic impact of Edward James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward James more than expected).

Fields of papers citing papers by Edward James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward James. The network helps show where Edward James may publish in the future.

Co-authorship network of co-authors of Edward James

This figure shows the co-authorship network connecting the top 25 collaborators of Edward James. A scholar is included among the top collaborators of Edward James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward James. Edward James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Post, Robert S., et al.. (2020). Metastatic Gastric Signet Ring Cell Adenocarcinoma Masquerading as Low Back Pain. Cureus. 12(11). e11297–e11297. 1 indexed citations
2.
3.
Mancini, B.R., Stacey Stein, Shane Lloyd, et al.. (2018). Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. Journal of Gastrointestinal Oncology. 9(6). 982–988. 6 indexed citations
4.
Stein, Stacey, Edward James, Yanhong Deng, et al.. (2016). Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. British Journal of Cancer. 114(7). 737–743. 153 indexed citations
5.
James, Edward, Xiangyu Cong, Xiaopan Yao, et al.. (2015). Final analysis of a phase II study of Yale-modified FOLFIRINOX (mFOLFIRINOX) in metastatic pancreatic cancer (MPC).. Journal of Clinical Oncology. 33(3_suppl). 395–395. 11 indexed citations
6.
James, Edward, Kacie R. Carlson, Antonio Subtil, et al.. (2014). CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature. Leukemia & lymphoma. 56(4). 951–957. 37 indexed citations
7.
James, Edward, Xiaopan Yao, Xiangyu Cong, et al.. (2014). Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC).. Journal of Clinical Oncology. 32(15_suppl). e15226–e15226. 10 indexed citations
8.
James, Edward, Xiaopan Yao, Xiangyu Cong, et al.. (2014). Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC).. Journal of Clinical Oncology. 32(3_suppl). 256–256. 4 indexed citations
9.
10.
James, Edward, Gina G. Chung, Mary Beth Clark, et al.. (2013). Phase I study of the HDAC inhibitor vorinostat in combination with capecitabine in a biweekly schedule in advanced breast cancer.. Journal of Clinical Oncology. 31(26_suppl). 154–154. 5 indexed citations
11.
James, Edward, Gina G. Chung, Michael P. DiGiovanna, et al.. (2013). Phase I study of the HDAC inhibitor vorinostat in combination with capecitabine in a biweekly schedule in advanced breast cancer.. Journal of Clinical Oncology. 31(15_suppl). 2587–2587. 1 indexed citations
12.
James, Edward, Maeve Waldron-Lynch, & Muhammad Wasif Saif. (2009). Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature. Anti-Cancer Drugs. 20(7). 634–638. 36 indexed citations
13.
James, Edward, et al.. (2009). Oxaliplatin-Induced Immune Thrombocytopenia: Another Cumulative Dose-Dependent Side Effect?. Clinical Colorectal Cancer. 8(4). 220–224. 29 indexed citations
14.
Isufi, Iris, et al.. (2009). Pregabalin (PGB) in treatment of oxaliplatin-induced neuropathy. Journal of Clinical Oncology. 27(15_suppl). e15045–e15045. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingbo Yi Breakdown of academic impact, for papers by A. Fittipaldo Breakdown of academic impact, for papers by Ana B. Galván Breakdown of academic impact, for papers by Tyler Izatt Breakdown of academic impact, for papers by Susan Valmadre Breakdown of academic impact, for papers by N. Vardakis Breakdown of academic impact, for papers by Sun Chung Breakdown of academic impact, for papers by Francesca Vecchione Breakdown of academic impact, for papers by Ulrika A. Hänninen Breakdown of academic impact, for papers by Akiko Ogiya
Rankless by CCL
2026